These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 7679244
21. Nonalternans repolarization variability and arrhythmia - the calcium connection. Němec J. J Electrocardiol; 2016; 49(6):877-882. PubMed ID: 27600096 [Abstract] [Full Text] [Related]
22. Effect of ranolazine on ventricular repolarization in class III antiarrhythmic drug-treated rabbits. Frommeyer G, Kaiser D, Uphaus T, Kaese S, Osada N, Rajamani S, Belardinelli L, Breithardt G, Eckardt L, Milberg P. Heart Rhythm; 2012 Dec; 9(12):2051-8. PubMed ID: 23044390 [Abstract] [Full Text] [Related]
24. Efficacy of oral sotalol in suppression of premature ventricular complexes and analysis of its beta-adrenergic blocking activity. Giorgi C, Nadeau R, Agha A, Primeau R, de Champlain J. Can J Cardiol; 1990 Jun; 6(5):191-7. PubMed ID: 1696514 [Abstract] [Full Text] [Related]
25. Usefulness of d, I sotalol for suppression of chronic ventricular arrhythmias. Anastasiou-Nana MI, Gilbert EM, Miller RH, Singh S, Freedman RA, Keefe DL, Saksena S, MacNeil DJ, Anderson JL. Am J Cardiol; 1991 Mar 01; 67(6):511-6. PubMed ID: 1705386 [Abstract] [Full Text] [Related]
26. Relation between ventricular function and antiarrhythmic responses to sotalol. Singh SN, Chen YW, Cohen A, Obeid M, Tracy C, Woosley RL, Fletcher RD. Am J Cardiol; 1989 Oct 15; 64(14):943-5. PubMed ID: 2801566 [No Abstract] [Full Text] [Related]
27. Practical considerations in the use of sotalol for ventricular tachycardia and ventricular fibrillation. Campbell RW, Furniss SS. Am J Cardiol; 1993 Aug 12; 72(4):80A-85A. PubMed ID: 8346732 [Abstract] [Full Text] [Related]
28. Effect of sotalol on RR interval variability during induced ventricular tachycardia. Yli-Mäyry S, García-Alberola A, Haverkamp W, Hindricks G, Martínez-Rubio A, Borggrefe M, Breithardt G. Am J Cardiol; 1996 Aug 01; 78(3):372-6. PubMed ID: 8759826 [Abstract] [Full Text] [Related]
35. Clinical assessment of adrenergic tone and responsiveness to beta-blocker therapy in patients with symptomatic ventricular tachycardia and no apparent structural heart disease. Brodsky MA, Orlov MV, Allen BJ, Orlov YS, Wolff L, Winters R. Am Heart J; 1996 Jan 01; 131(1):51-8. PubMed ID: 8554019 [Abstract] [Full Text] [Related]
37. Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs. Thomsen MB, Verduyn SC, Stengl M, Beekman JD, de Pater G, van Opstal J, Volders PG, Vos MA. Circulation; 2004 Oct 19; 110(16):2453-9. PubMed ID: 15477402 [Abstract] [Full Text] [Related]
38. [Regional differences in frequency-corrected QT duration in multi-electrode ECG in ventricular extrasystole]. Nahrendorf W, Faber G, Benndorf S, Rading A, Steinig G. Z Gesamte Inn Med; 1986 Jul 01; 41(13):382-4. PubMed ID: 2429463 [Abstract] [Full Text] [Related]